Hypertension and the kidneys.
Cardiovascular disease
Chronic kidney disease
End-stage kidney disease
Hypertension
Journal
British journal of hospital medicine (London, England : 2005)
ISSN: 1750-8460
Titre abrégé: Br J Hosp Med (Lond)
Pays: England
ID NLM: 101257109
Informations de publication
Date de publication:
02 May 2022
02 May 2022
Historique:
entrez:
2
6
2022
pubmed:
3
6
2022
medline:
7
6
2022
Statut:
ppublish
Résumé
Hypertension is a leading risk factor for cardiovascular disease and all-cause mortality globally. Hypertension and chronic kidney disease are closely intertwined conditions as hypertension can lead to deteriorating renal function and progressive chronic kidney disease can contribute to worsening hypertension. In the setting of chronic kidney disease, the pathophysiology of hypertension is complex and involves the interplay of many factors including a reduced number of functioning nephrons, sodium retention and volume expansion, upregulation of the sympathetic nervous system, hormonal factors such as upregulation of the renin-angiotensin-aldosterone system, and endothelial dysfunction. Poorly controlled hypertension can accelerate the progression to end-stage kidney disease. This review discusses the pathophysiological mechanisms that contribute to hypertension, including sympathetic nervous system activity, the renin-angiotensin-aldosterone system and the role of sodium. In the setting of chronic kidney disease, the relationship with hypertension and renovascular disease as a potential cause and target for therapeutic intervention is briefly reviewed. Finally, treatment options, targets and the long-term cardiovascular benefits of optimal blood pressure control are discussed.
Identifiants
pubmed: 35653320
doi: 10.12968/hmed.2021.0440
doi:
Substances chimiques
Sodium
9NEZ333N27
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM